Tongfu Lifei Decoction Attenuated Sepsis-Related Intestinal Mucosal Injury Through Regulating Th17/Treg Balance and Modulating Gut Microbiota

• Published in: Journal of interferon & cytokine research Vol. 44; no. 5; p. 208
• Main Authors: Chen, Huizhen, Yu, Zhenfei, Qi, Zeming, Huang, Xiaozhe, Gao, Jianting
• Format: Journal Article
• Language: English
• Published: United States 01.05.2024
• Subjects: Animals; Drugs, Chinese Herbal - pharmacology; Gastrointestinal Microbiome - drug effects; Intestinal Mucosa - drug effects; Intestinal Mucosa - immunology; Intestinal Mucosa - microbiology; Intestinal Mucosa - pathology; Male; Rats; Rats, Sprague-Dawley; Sepsis - complications; Sepsis - drug therapy; Sepsis - immunology; T-Lymphocytes, Regulatory - drug effects; T-Lymphocytes, Regulatory - immunology; Th17 Cells - drug effects; Th17 Cells - immunology; Tongfu Lifei decoction; intestinal barrier; Th17/Treg; gut microbiota; sepsis
• ISSN: 1557-7465
• DOI: 10.1089/jir.2024.0001

Intestinal damage and secondary bacterial translocation are caused by the inflammatory response induced by sepsis. Tongfu Lifei (TLF) decoction has a protective effect on sepsis-related gastrointestinal function injury. However, the relation between gut microbiota, immune barrier, and sepsis under the treatment of TLF have not been well clarified yet. Here, rats were subjected to cecal ligation and puncture (CLP) to create a sepsis model. Subsequently, the TLF decoction was given to CLP rats by gavage, fecal microbiota transplantation (FMT), and antibiotic were used as positive control. TLF suppressed the inflammatory response and improved the pathological changes in the intestines of CLP rats. Besides, TLF promoted the balance of the percentage of the Th17 and Treg cells. Intestinal barrier function was also improved by TLF through enhancing ZO-1, and Occludin and Claudin 1 expression, preventing the secondary translocation of other gut microbiota. TLF dramatically boosted the gut microbiota's alpha- and beta-diversity in CLP rats. Moreover, it increased the relative abundance of anti-inflammatory gut microbiota and changed the progress of the glucose metabolism. In short, TLF regulated the gut microbiota to balance the ratio of Th17/Treg cells, reducing the inflammation in serum and intestinal mucosal injury in rats.